Clinical Trials Directory

Trials / Terminated

TerminatedNCT02212210

Maternal Epidural Steroids and Hyperthemia

Maternal Epidural Steroids to Prevent Neonatal Exposure to Hyperthermia and Inflammation

Status
Terminated
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
135 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to look to see if adding steroids to an epidural reduces the chances of having a fever in labor, and protects the baby from exposure to inflammation.

Detailed description

The association between epidural analgesia and increased maternal intrapartum temperature has been well documented in multiple randomized controlled trials. The exact mechanism for this elevation in temperature is unknown; however the most likely cause appears to be non-infectious inflammatory stimulation. Fetal exposure to maternal fever in utero has been linked with increased antibiotic treatment, increased neonatal sepsis evaluation, and longer length of stay for neonates. In addition there is evidence to suggest intrapartum fevers may lower the threshold for fetal hypoxic brain injury and increase the risk of cerebral palsy. The risk of neonatal encephalopathy in infants born to febrile mothers is 1% compared to 0.1% to afebrile mothers. Safe interventions are needed to prevent adverse fetal outcomes.

Conditions

Interventions

TypeNameDescription
DRUGMethylprednisolone
DRUGNormal saline

Timeline

Start date
2012-02-01
Primary completion
2014-04-01
Completion
2015-10-01
First posted
2014-08-08
Last updated
2017-08-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02212210. Inclusion in this directory is not an endorsement.